tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Zymeworks Inc (ZYME)
NASDAQ:ZYME
US Market
ZYME
Zymeworks
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Zymeworks (ZYME) Stock News & Sentiment

Compare
524 Followers
Zymeworks’ Promising Clinical Developments and Strategic Positioning Justify Buy Rating
Premium
Ratings
Zymeworks’ Promising Clinical Developments and Strategic Positioning Justify Buy Rating
14d ago
ZYME
Zymeworks: Hold Rating Amidst Milestone Achievements and Future Uncertainties
Premium
Ratings
Zymeworks: Hold Rating Amidst Milestone Achievements and Future Uncertainties
15d ago
ZYME
Zymeworks: Strategic Milestones and Promising Clinical Results Justify Buy Rating
Premium
Ratings
Zymeworks: Strategic Milestones and Promising Clinical Results Justify Buy Rating
18d ago
ZYME
Zymeworks’ Zanidatamab: Promising Potential in HER2-Positive Cancer Treatment and Strategic Market Positioning Justify Buy Rating
Premium
Ratings
Zymeworks’ Zanidatamab: Promising Potential in HER2-Positive Cancer Treatment and Strategic Market Positioning Justify Buy Rating
18d ago
ZYME
Zymeworks’ Zanidatamab Receives NMPA Approval in China for HER2+ Biliary Tract Cancer
Premium
Company Announcements
Zymeworks’ Zanidatamab Receives NMPA Approval in China for HER2+ Biliary Tract Cancer
18d ago
ZYME
Zymeworks Showcases Oncology Advances at Major Conferences
Premium
Company Announcements
Zymeworks Showcases Oncology Advances at Major Conferences
25d ago
ZYME
Zymeworks to Engage Investors at Upcoming Conferences
Premium
Company Announcements
Zymeworks to Engage Investors at Upcoming Conferences
27d ago
ZYME
More ZYME News >

ZYME News on the Web

Wall Street Analysts See a 76.74% Upside in Zymeworks (ZYME): Can the Stock Really Move This High?
Zacks
Bullish
Wall Street Analysts Think Zymeworks (ZYME) Could Surge 83.89%: Read This Before Placing a Bet
Zacks
Bullish
Why Zymeworks Inc.amp;#8217;s (ZYME) Stock Is Up 5.79%
AAII
Neutral
Why Zymeworks Inc.amp;#8217;s (ZYME) Stock Is Up 6.10%
AAII
Neutral
Zymeworks (ZYME) Surpasses Revenue Expectations in Q1 | ZYME Stock News
GuruFocus News
Bullish
Zymeworks Inc. (ZYME) Reports Q1 Loss, Tops Revenue Estimates
Zacks
Neutral
Zymeworks Updates Communication Channels for Stakeholders
TipRanks News
Neutral
Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting | ...
GuruFocus News
Neutral

News Score - Last 7 Days

Neutral
ZYME
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week100%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ZYME’s Media Buzz Sentiment?
Currently, no data Available
What is ZYME’s weekly average amount of articles?
Currently, no data Available
What is ZYME’s News Sentiment?
100% of articles about ZYME were positive this week, compared to its sector average of 56%.
    Healthcare Stocks that are Trending in the News
    ELANElanco Animal Health
    INSMInsmed
    AVDLAvadel Pharmaceuticals
    AMRXAmneal Pharmaceuticals
    BAYRYBayer
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing